Event · 📍 Congo - Kinshasa · first report 04 Nov 2026, 17:56 UTC · latest 05 Nov 2026, 12:00 UTC
WHO genehmigt klinische Studien für zwei neue Ebola-Impfstoffe
4 sources 4 independent 🌐 3 languages
Corroboration: at least 3 independent newsrooms. How we count
Evidence profile
- Independent origins: 4 from 4 reports
- Official source: UN News
- Measurements: no monitoring networks for this kind of event
- Contradictions: none detected
Timeline
- 04 Nov 2026, 17:56 UTC First report: Stern
- 04 Nov 2026, 19:22 UTC New independent origin: Al Jazeera English
- 04 Nov 2026, 19:22 UTC First report from Qatar / global (Al Jazeera English)
- 04 Nov 2026, 19:22 UTC dead: 5,300 (Al Jazeera English)
- 05 Nov 2026, 06:00 UTC New independent origin: Infobae
- 05 Nov 2026, 06:00 UTC First report from Argentina / Latin America (Infobae)
- 05 Nov 2026, 12:00 UTC New independent origin: UN News
- 05 Nov 2026, 12:00 UTC First report from International (UN News)
- 05 Nov 2026, 12:00 UTC Official / primary source: UN News
Share: WhatsApp · Telegram · X · Bluesky · Facebook · LinkedIn · Reddit · E-mail
Perspectives: who reports from where?
Germany (1)
- Stern 04 Nov 2026, 17:56 UTC
WHO genehmigt klinische Studien für zwei neue Ebola-Impfstoffe
Inmitten der Ebola-Epidemie in der Demokratischen Republik Kongo hat die Weltgesundheitsorganisation (WHO) klinische Studien für zwei neue Impfstoffe genehmigt. Die beiden Vakzine seien speziell für die derzeit grassierende Ebola-Variante Bundibugyo entwickelt worden, teilte …
Qatar / global (1)
- Al Jazeera English 04 Nov 2026, 19:22 UTC
WHO approves trials for two new Ebola vaccines
Two new vaccines were designed for the Bundibugyo virus that has killed more than 5,300 in the DR Congo.
Argentina / Latin America (1)
- Infobae 05 Nov 2026, 06:00 UTC
La OMS alerta de una doble crisis de ébola y cólera en República Democrática del Congo
International (1)
- UN News 05 Nov 2026, 12:00 UTC
Two new Ebola vaccines to join DR Congo clinical trial
Two new Ebola vaccine candidates will be added to a clinical trial in the Democratic Republic of the Congo (DRC) as the country continues to battle a deadly outbreak caused by the Bundibugyo species of the virus.
Headlines in their original language, linked to the publishing newsroom. WorldWatchers does not check whether a report is true; we show who corroborates it and how.